Vivos Therapeutics (VVOS)
NASDAQ:VVOS
US Market
Holding VVOS?
Track your performance easily

Vivos Therapeutics (VVOS) Financial Statements

154 Followers

Vivos Therapeutics Financial Overview

Vivos Therapeutics's market cap is currently ―. The company's EPS TTM is $-10.318; its P/E ratio is -0.27; Vivos Therapeutics is scheduled to report earnings on August 13, 2024, and the estimated EPS forecast is $-1.05. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 3.42M$ 3.30M$ 3.40M$ 2.08M$ 4.13M
Gross Profit$ 1.94M$ 1.90M$ 2.10M$ 2.34M$ 2.57M
EBIT$ -3.79M$ -3.49M$ -5.61M$ 15.86M$ -5.99M
EBITDA$ -3.64M$ -3.34M$ -5.46M$ 15.69M$ -5.82M
Net Income Common Stockholders$ -3.76M$ -2.09M$ -5.53M$ 9.48M$ -5.90M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 2.60M$ 1.00M$ 3.90M$ 7.00M$ 3.50M
Total Assets$ 11.80M$ 10.32M$ 13.71M$ 17.10M$ 13.72M
Total Debt$ 1.88M$ 2.10M$ 2.21M$ 2.31M$ 2.41M
Net Debt$ -718.00K$ 1.10M$ -1.69M$ -4.68M$ -1.09M
Total Liabilities$ 11.20M$ 10.30M$ 11.64M$ 10.10M$ 8.90M
Stockholders Equity$ 582.00K$ 46.00K$ 2.10M$ 6.99M$ 4.80M
Cash Flow-
Free Cash Flow$ -2.65M$ -2.95M$ -3.13M$ -3.80M$ -3.20M
Operating Cash Flow$ -2.50M$ -2.80M$ -2.88M$ -3.51M$ -3.00M
Investing Cash Flow$ -151.00K$ -154.00K$ -245.00K$ -289.00K$ -200.00K
Financing Cash Flow$ 3.63M--$ 7.36M-
Currency in USD

Vivos Therapeutics Earnings and Revenue History

Vivos Therapeutics Debt to Assets

Vivos Therapeutics Cash Flow

Vivos Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis